New Key Statistics Module, Z-Score and F-Score
OTCPK:HLTRF Key Ratios
| Market Cap $ M | 87.16 |
| Enterprise Value $ M | 153.42 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.99 |
| Price/Sales | 1.47 |
| Price/Free Cash Flow | 7.13 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 60.00 |
| EPS (TTM) $ | -0.86 |
| Beneish M-Score | -3.3 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -10.00 |
| y-y EBITDA Growth Rate % | -30.40 |
| EV-to-EBIT | -8.23 |
| EV-to-EBITDA | 14.08 |
| PEG | -- |
| Shares Outstanding M | 31.81 |
| Net Margin (%) | -45.77 |
| Operating Margin % | -17.51 |
| Pre-tax Margin (%) | -46.21 |
| Quick Ratio | 1.17 |
| Current Ratio | 1.56 |
| ROA % (ttm) | -12.79 |
| ROE % (ttm) | -26.70 |
| ROIC % (ttm) | -5.62 |
| Dividend Yield % | 1.29 |
| Altman Z-Score | -0.71 |
HLTRF Number of Guru Trades
HLTRF Volume of Guru Trades
Gurus Latest Trades with OTCPK:HLTRF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:HLTRF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HLS Therapeutics Inc Insider Transactions
No Available Data
News about OTCPK:HLTRF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers